AE, S., K, O., R, F., R, S., JA, T., C, P., . . . GQ, D. P. (2025). The TLR7 agonist vesatolimod does not measurably induce SIV expression in macaques receiving combination antiretroviral therapy initiated during chronic infection. Antimicrobial agents and chemotherapy, 69(11), e0107325. https://doi.org/10.1128/aac.01073-25
Chicago Style (17th ed.) CitationAE, Swanstrom, et al. "The TLR7 Agonist Vesatolimod Does Not Measurably Induce SIV Expression in Macaques Receiving Combination Antiretroviral Therapy Initiated During Chronic Infection." Antimicrobial Agents and Chemotherapy 69, no. 11 (2025): e0107325. https://doi.org/10.1128/aac.01073-25.
MLA (9th ed.) CitationAE, Swanstrom, et al. "The TLR7 Agonist Vesatolimod Does Not Measurably Induce SIV Expression in Macaques Receiving Combination Antiretroviral Therapy Initiated During Chronic Infection." Antimicrobial Agents and Chemotherapy, vol. 69, no. 11, 2025, p. e0107325, https://doi.org/10.1128/aac.01073-25.
